Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Equity (2016 - 2025)

Bioadaptives' Return on Equity history spans 7 years, with the latest figure at 0.01% for Q4 2025.

  • On a quarterly basis, Return on Equity rose 1.0% to 0.01% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% increase, with the full-year FY2025 number at 0.01%, changed 0.0% from a year prior.
  • Return on Equity hit 0.01% in Q4 2025 for Bioadaptives, up from 0.01% in the prior quarter.
  • Over the last five years, Return on Equity for BDPT hit a ceiling of 0.01% in Q1 2021 and a floor of 0.0% in Q3 2024.
  • Historically, Return on Equity has averaged 0.01% across 5 years, with a median of 0.01% in 2025.
  • Biggest five-year swings in Return on Equity: decreased -1bps in 2023 and later rose 1bps in 2025.
  • Tracing BDPT's Return on Equity over 5 years: stood at 0.01% in 2021, then decreased by -15bps to 0.01% in 2022, then tumbled by -76bps to 0.0% in 2023, then surged by 141bps to 0.0% in 2024, then skyrocketed by 126bps to 0.01% in 2025.
  • Business Quant data shows Return on Equity for BDPT at 0.01% in Q4 2025, 0.01% in Q3 2025, and 0.01% in Q2 2025.